1Kimiko Ueda,Ichiro Kawachi,Hideaki Tsukuma.Cervical and corpus cancer survival disparities by socioeconomic status in a metropolitan area of Japan,Cancer Science,2006,97(4):283-291.
2Bielska-Lasota M,Krynicki R,Rabczenko D.Survival of cervical cancer patients in selected regions of Poland in 1990-1996,in relation to some prognostic factors.Przegl Epidemiol,2004,58(3):523-536.
3Psychometric analysis of the Functional Assessment of Cancer Therapy General(FACT-G)scale in a rural sample.Cancer,2000,79:2446.
4Rutledge TL,Kamelle SA,Tillmanns TD,et al.A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy.Is size the real difference.Gynecol Oncol,2004,95(1):70-76.
1WHO Guidelines Approved by the Guidelines Review Committee. Comprehensive cervical cancer control: a guide to essential practice [R]. 2nd. Geneva:WHO ,2014.
2Peiretti M, Zapardiel I, Zanagnolo V, et al. Management of recurrent cervical cancer:a review of the literature [ J ]. Surg Oncoi, 2012,21 (2) : e59-66.
3Sardain H, Lavoue V, Redpath M, et al. Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review [J]. Eur J Surg Oncol, 2015,41 ( 8 ) :975-985.
4Brunschwig A. The surgical treatment of cancer of the cervix uteri; a radical operation for cancer of the cervix [J]. Bull N Y Acad Med, 1948,24(10) :672-683.
5Berek JS, Howe C, Lagasse LD, et al. Pelvic exenteration for recurrent gynecologic malignancy:survival and morbidity analysis of the 45-year experience at UCLA[J]. Gynecol Oncol,2005,99( 1 ) :153-159.
6Fomer M, Lampe B. Exenteration as a primiary treatment for locally advanced cervical cancer:longterm results and prognostic thctors[J]. Am J Obstet Gyneco1,2011,205 ( 2 ) : 148.
7Bipat S,Glas AS, van der Velden J, et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma : a systematic review [ J ]. Gynecol Onco1,2003,91 ( 1 ) :59-66.
8Forner DM, Meyer A, Lampe B. Preoperative assessment of complete tumour resection by magnetic resonance imaging in patients undergo- ing pelvic exenteration[J]. Eur J Obstet Gynecol Reprod Biol,2010, 148(2) : 182-185.
9Husain A, Akhurst T, Larson S, et al. A prospective study of the accu- racy of 18Fluorodeoxyglueose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration [J]. Gynecol Oncol, 2007,106 ( 1 ) : 177-180.
10Kitajima L, Suenaga Y, Ueno Y, et al. Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumor:com- parison with F-FDG contrast-enhanced PET/CT and pelvic MRI[ J]. Ann Nucl Med,2014,28( 1 ) :25-32.
